Skip to content
Discover Servier

Welcome to Servier in the U.S.

About
Servier Group
in the U.S.

Improving the lives of our patients

We work tirelessly to deliver meaningful therapeutic progress to the patients we serve.

Learn more
in the U.S.

About Us

We are a privately held pharmaceutical leader in oncology, dedicated to addressing challenging and hard-to-treat diseases. Our unwavering commitment is centered on delivering the promise of a brighter tomorrow to the patients we serve.

Learn more
in the U.S.

Research & Development

We are moved by science. To address the unmet need of patients, our practice changing R&D pipeline and in-house capabilities are complimented by a robust partnership network.

Research & Development

oncology

Our Areas of Focus

Acute lymphoblastic leukemia

The most common type of childhood leukemia

Acute myeloid leukemia

The most common acute leukemia affecting adults

Cholangio- carcionoma

A rare and aggressive type of cancer that affects the bile ducts

Biomarker Testing

IDH-mutations and their role in cancer diagnosis.

ONCOLOGY PIPELINE

We continue to build our treatment portfolio with a current focus on oncology within the United States

See the pipeline
+35 ONCOLOGY PROJECTS
16 Early research projects
9 Phase 1
2 Phase 2
2 Phase 3
2 Currently Filing

CAREER

See a future at Servier?

Learn more about working at Servier and search our current job openings to see if there is a career opportunity for you.

Join our team

NEWSROOM

Latest news

Access to the newsroom